To identify the compounds with potent inhibitory effects on EGFR wild-type lung cancer cells, we modified gefitinib through a click reaction by introducing a 1,2,3-triazole moiety to its structure (Figure 3). This evidence concerns the gene EGFR and lung carcinoma.